Case Reports
Vol. 62 No. 3 (2010)
https://doi.org/10.4081/reumatismo.2010.221

Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1368
Views
854
Downloads

Authors

M. Gutierrez
office@pagepress.org
, Italy.
A. Becciolini
, Italy.
C. Bertolazzi
, Italy.
L. Di Geso
, Italy.
M. Tardella
, Italy.
A. Ariani
, Italy.
E. Filippucci
, Italy.
W. Grassi
, Italy.
Over the last ten years, the treatment of seronegative spondyloarthropathies has changed dramatically with the introduction of the anti-tumor necrosis factor alpha (TNFα) agents. Nevertheless, there is a growing number of studies describing several adverse reactions in patients treated with biological agents. In the present report we describe the case of a 22-year-old male patient with ankylosing spondylitis who developed a “paradoxic” adverse reaction, while receiving infliximab.

Downloads

Download data is not yet available.

How to Cite



1.
Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab. Reumatismo [Internet]. 2010 Sep. 30 [cited 2026 Sep. 19];62(3):221-4. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2010.221

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.